GSK Drug Halves Attacks in Hard-to-Treat Asthma
GSK drug halves attacks in hard-to-treat asthma
Filed under: drug treatment news stories
LONDON (Reuters) – An experimental drug for treating severe asthma from GlaxoSmithKline nearly halved the number of attacks suffered by patients with a hard-to-treat form of the disease in a clinical study, boosting hopes for its commercial success …
Read more on Chicago Tribune
Former NFL quarterback Ray Lucas hopes story of painkiller addiction will lead …
Filed under: drug treatment news stories
Lucas, 39, serves as a spokesman for TurnToHelp.com, a website that encourages people with an opioid dependence to find a doctor and get treated. The site is sponsored by Reckitt Benckiser Pharmaceuticals Inc., the maker of the anti-addiction drug …
Read more on CBS News
GSK Drug Halves Attacks In Hard-to-treat Asthma
LONDON (Reuters) – An experimental drug for treating severe asthma from GlaxoSmithKline nearly halved the number of attacks suffered by patients with a hard-to-treat form of the disease in a clinical study, boosting hopes for its commercial success. Britain's biggest drugmaker – already a world leader in respiratory medicine – said as a result it planned to move the new drug into final Phase III … Read News
Experimental Drug Halves Attacks In Hard-to-treat Asthma
An experimental drug for treating severe asthma from GlaxoSmithKline nearly halved the number of attacks suffered by patients with a hard-to-treat form of the disease in a clinical study, boosting hopes for its commercial success … Read News